ECSP992937A - ACTIVE PROTEIN ERIZO CONJUGATES, PROCESS FOR THEIR PRODUCTION AND USE - Google Patents

ACTIVE PROTEIN ERIZO CONJUGATES, PROCESS FOR THEIR PRODUCTION AND USE

Info

Publication number
ECSP992937A
ECSP992937A ECSP992937A ECSP992937A EC SP992937 A ECSP992937 A EC SP992937A EC SP992937 A ECSP992937 A EC SP992937A EC SP992937 A ECSP992937 A EC SP992937A
Authority
EC
Ecuador
Prior art keywords
erizo
conjugates
production
active protein
hydrophobic
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Kurt Lang
Tilman Seytter
Angelika Esswein
Petra Rueger
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP992937 priority Critical patent/ECSP992937A/en
Publication of ECSP992937A publication Critical patent/ECSP992937A/en

Links

Landscapes

  • Peptides Or Proteins (AREA)

Abstract

Un conjugado de proteína erizo que se caracteriza porque contiene: a) un polipéptido compuesto de 10 a 30 aminoácidos hidrofóbicos y/o de aminoácidos que forman helicoides transmembránicos y está cargado positivamente, b) 1 a 4 residuos de hidrocarburos alifáticos, saturados o sin saturar con una longitud de cadena de 10 a 24 átomos de C y con una acción hidrofóbica, ó c) un tio compuesto hidrofóbico, unido covalentemente a una proteína erizo, y el cual tiene una actividad varias veces mayor y es adecuado como agente farmacéutico.A hedgehog protein conjugate characterized in that it contains: a) a polypeptide composed of 10 to 30 hydrophobic amino acids and / or amino acids that form transmembrane helicoids and is positively charged, b) 1 to 4 aliphatic hydrocarbon residues, saturated or unsaturated with a chain length of 10 to 24 C atoms and with a hydrophobic action, or c) a hydrophobic compound thio, covalently linked to a hedgehog protein, and which has several times greater activity and is suitable as a pharmaceutical agent.

ECSP992937 1999-04-30 1999-04-30 ACTIVE PROTEIN ERIZO CONJUGATES, PROCESS FOR THEIR PRODUCTION AND USE ECSP992937A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP992937 ECSP992937A (en) 1999-04-30 1999-04-30 ACTIVE PROTEIN ERIZO CONJUGATES, PROCESS FOR THEIR PRODUCTION AND USE

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP992937 ECSP992937A (en) 1999-04-30 1999-04-30 ACTIVE PROTEIN ERIZO CONJUGATES, PROCESS FOR THEIR PRODUCTION AND USE

Publications (1)

Publication Number Publication Date
ECSP992937A true ECSP992937A (en) 2000-11-24

Family

ID=42043927

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP992937 ECSP992937A (en) 1999-04-30 1999-04-30 ACTIVE PROTEIN ERIZO CONJUGATES, PROCESS FOR THEIR PRODUCTION AND USE

Country Status (1)

Country Link
EC (1) ECSP992937A (en)

Similar Documents

Publication Publication Date Title
ECSP056159A (en) CONJUGATED DRUG COMPOSITION
ATE541587T1 (en) CONJUGATE ADDITION REACTIONS FOR THE CONTROLLED RELEASE OF PHARMACEUTICALLY ACTIVE SUBSTANCES
NZ599176A (en) Immunoconjugate formulations
PE20120586A1 (en) IL-1 BINDING PROTEINS
AR072596A1 (en) A PROTEIN COMPLEX THAT INCLUDES A DIMERICAL PROTEIN AND A NON-PEPTIDIC POLYMER
ES2074042T3 (en) RECOMBINANT EXOTOXIN OF PSEUDOMONAS CONSTRUCTION OF AN ACTIVE IMMUNOTOXIN WITH MINOR SIDE EFFECTS.
BR0012926A (en) Chimeric polypeptides, method for their production and uses
ES2190087T3 (en) STABILIZED FORMULATION OF AN ANTIBODY.
DE69614849D1 (en) CHIMEAN LIPID BODY PRO-GRF ANALOG WITH INCREASED BIOLOGICAL POTENTIAL
DE69934337D1 (en) Conjugates for the treatment of inflammatory diseases and associated tissue damage
HUP9901411A2 (en) Active hedgehog protein conjugate, process for its production and use
BR9811094A (en) Therapeutic agent for lymphatic tumors
PT97743A (en) PROCESS FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS BEHAVIORING BACLOFEN AS AN ACTIVE INGREDIENT INTENDED FOR THE TREATMENT OF BREAST ANGINE
BR9913515A (en) Analog of hydrophobic graph, pharmaceutical formulation, use of graph analog, and, process for the diagnosis of growth hormone deficiencies in patients
WO2020220044A3 (en) Self-assembling protein nanocage decorated with antibodies (sapna) and parts thereof
PE20030214A1 (en) PROCEDURE FOR RAPID SYNTHESIS OF PEPTIDES IN SOLUTION
ES2164385T3 (en) GAS SPRING WITH ADJUSTABLE LENGTH.
CO5050328A1 (en) SOLVENT SYSTEM FOR THE BEST PENETRATION OF PHARMACEUTICAL COMPOUNDS
CR7936A (en) PARENTERAL FORMULATIONS OF A PEPTIDE FOR THE TREATMENT OF SITEMIC ERITEMATOSUS LUPUS
ES2185671T3 (en) CYCLE DEPSIPEPTIDES CONTAINING LACTIC ACID WITH 18 ATOMS IN THE RING AS ENDOPARASTICID AGENTS AND PROCEDURE FOR OBTAINING IT.
MX2024001301A (en) ANTIBODIES AND ANTIBODY CONJUGATES SPECIFIC TO NECTIN 4 AND METHODS OF USE THEREOF.
EA199800717A1 (en) METHOD FOR THE TREATMENT OF MAMMAL DISEASES AND THE CYVITTERION COMPOSITION
ES2061828T3 (en) ANTIIRRITANT AND DESENSITIZING COMPOSITIONS AND METHODS FOR USE.
ES2195040T3 (en) CONJUGADO THAT INCLUDES AN ACTIVE PRINCIPLE, A POLYPEPTIDE AND VARIOUS POLIETERES AND ITS USE AS A MEDICINAL PRODUCT.
AR056137A1 (en) AN IMMUNOGLOBULIN PEPTIDE CONJUGATE AND ITS USE AS ANTIVIRAL